Abbott Laboratories Inc reported a 37% rise in quarterly profit on Wednesday, driven by demand for its heart devices and FreeStyle Libre system used to monitor blood sugar levels.
The company's net earnings rose to $1 billion, or 56 cents per share, in the second quarter ended June 30, from $733 million, or 41 cents per share, a year earlier.
Net sales of the company, whose products include infant nutritional formula, rose 2.7% to $7.98 billion from $7.77 billion.
(Reporting by Saumya Sibi Joseph and Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila) ((saumya.joseph@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 2290; Reuters Messaging: saumya.joseph.thomsonreuters.com@reuters.net))
